← 產業報告目錄
Antimicrobial Peptides Market Size, Share & Trends Analysis Report By Product (Plant Antimicrobial Peptides, Bacterial Antimicrobial Peptides, Animal Antimicrobial Peptides, Insect Antimicrobial Peptides), By Ailments, By Route of Administration, By End User, By Distribution Channel, By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-01頁數 180報告編號 INSIGHTACE-37f09f7fa2
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2024, the Antimicrobial Peptides Market worldwide was assessed at USD 248.53 Mn. Analysts project it will progress to USD 759.86 Mn by 2034, at a CAGR of 11.9% spanning 2025 to 2034.
Antimicrobial Peptides encompasses challenges.
Market momentum is supported by escalating interest in advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region set to deliver the strongest growth trajectory through the forecast period, supported by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Antimicrobial Peptides Market Snapshot
Chapter 4. Global Antimicrobial Peptides Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product Type:
5.2.1. Plant Antimicrobial Peptides
5.2.2. Bacterial Antimicrobial Peptides
5.2.3. Animal Antimicrobial Peptides
5.2.4. Insect Antimicrobial Peptides
Chapter 6. Market Segmentation 2: by Ailments Estimates & Trend Analysis
6.1. by Ailments & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Ailments:
6.2.1. Pneumonia
6.2.2. Hepatitis
6.2.3. Bacterial infections
6.2.4. HIV
Chapter 7. Market Segmentation 3: by Route of Administration Estimates & Trend Analysis
7.1. by Route of Administration & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Route of Administration:
7.2.1. Topical
7.2.2. Subcutaneous
7.2.3. Intravenous
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. By End User & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:
8.2.1. Pharma and Healthcare
8.2.2. Agriculture Industry
8.2.3. Biological Engineering
8.2.4. Others
Chapter 9. Market Segmentation 5: by Distribution Channel Estimates & Trend Analysis
9.1. by Distribution Channel & Market Share, 2024 & 2034
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Distribution Channel:
9.2.1. Hospital
9.2.2. Research Institutes
9.2.3. Specialty Clinic
9.2.4. Pharmacies
Chapter 10. Antimicrobial Peptides Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Antimicrobial Peptides Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
10.1.2. North America Antimicrobial Peptides Market Revenue (US$ Million) Estimates and Forecasts by Ailments, 2021-2034
10.1.3. North America Antimicrobial Peptides Market revenue (US$ Million) by Route of Administration, 2021-2034
10.1.4. North America Antimicrobial Peptides Market revenue (US$ Million) By End User, 2021-2034
10.1.5. North America Antimicrobial Peptides Market revenue (US$ Million) by Distribution Channel, 2021-2034
10.1.6. North America Antimicrobial Peptides Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.2. Europe
10.2.1. Europe Antimicrobial Peptides Market revenue (US$ Million) by Product Type, 2021-2034
10.2.2. Europe Antimicrobial Peptides Market revenue (US$ Million) by Ailments, 2021-2034
10.2.3. Europe Antimicrobial Peptides Market revenue (US$ Million) by Route of Administration, 2021-2034
10.2.4. Europe Antimicrobial Peptides Market revenue (US$ Million) By End User, 2021-2034
10.2.5. Europe Antimicrobial Peptides Market revenue (US$ Million) by Distribution Channel, 2021-2034
10.2.6. Europe Antimicrobial Peptides Market revenue (US$ Million) by country, 2021-2034
10.3. Asia Pacific
10.3.1. Asia Pacific Antimicrobial Peptides Market revenue (US$ Million) by Product Type, 2021-2034
10.3.2. Asia Pacific Antimicrobial Peptides Market revenue (US$ Million) by Ailments, 2021-2034
10.3.3. Asia-Pacific Antimicrobial Peptides Market revenue (US$ Million) by Route of Administration, 2021-2034
10.3.4. Asia Pacific Antimicrobial Peptides Market revenue (US$ Million) By End User, 2021-2034
10.3.5. Asia Pacific Antimicrobial Peptides Market revenue (US$ Million) by Distribution Channel, 2021-2034
10.3.6. Asia Pacific Antimicrobial Peptides Market revenue (US$ Million) by country, 2021-2034
10.4. Latin America
10.4.1. Latin America Antimicrobial Peptides Market revenue (US$ Million) by Product Type, 2021-2034
10.4.2. Latin America Antimicrobial Peptides Market revenue (US$ Million) by Ailments, 2021-2034
10.4.3. Latin America Antimicrobial Peptides Market revenue (US$ Million) by Route of Administration, 2021-2034
10.4.4. Latin America Antimicrobial Peptides Market revenue (US$ Million) By End User, 2021-2034
10.4.5. Latin America Antimicrobial Peptides Market revenue (US$ Million) by Distribution Channel, 2021-2034
10.4.6. Latin America Antimicrobial Peptides Market revenue (US$ Million) by country, 2021-2034
10.5. Middle East & Africa
10.5.1. Middle East & Africa Antimicrobial Peptides Market revenue (US$ Million) by Product Type, 2021-2034
10.5.2. Middle East & Africa Antimicrobial Peptides Market revenue (US$ Million) by Ailments, 2021-2034
10.5.3. Middle East & Africa Antimicrobial Peptides Market revenue (US$ Million) by Route of Administration, 2021-2034
10.5.4. Middle East & Africa Antimicrobial Peptides Market revenue (US$ Million) By End User, 2021-2034
10.5.5. Middle East & Africa Antimicrobial Peptides Market revenue (US$ Million) by Distribution Channel, 2021-2034
10.5.6. Middle East & Africa Antimicrobial Peptides Market revenue (US$ Million) by country, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Novozymes A/S
11.2.2. Polypeptide Group
11.2.3. Bachem Holding AG
11.2.4. Wuxi Apptec
11.2.5. Ana Spec Inc. (a Eurofins Company)
11.2.6. Merial
11.2.7. Ipsen S.A.
11.2.8. AstraZeneca
11.2.9. Pfizer Inc.
11.2.10. GlaxoSmithKline plc
11.2.11. Merck & Co. Inc.
11.2.12. Sandoz International GmbH
11.2.13. Polymedia
11.2.14. Magennis Inc.
11.2.15. Probiotic Limited
11.2.16. Eli Lilly and Company
11.2.17. Johnson & Johnson Private Limited
11.2.18. Melinta Therapeutics, LLC
11.2.19. Vertex Pharmaceuticals Incorporated
11.2.20. AMP Biotech
11.2.21. Phoenix Biotechnology Inc.
11.2.22. Novabiotics
11.2.23. Other prominent players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們